Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Syros Pharmaceuticals Inc. buy DomRuinart

Start price
€5.41
27.09.22 / 50%
Target price
€11.60
27.09.23
Performance (%)
8.69%
End price
€5.88
17.10.22
Summary
This prediction ended on 17.10.22 with a price of €5.88. With a performance of 8.69%, the BUY prediction by DomRuinart for Syros Pharmaceuticals Inc. closed with a slight gain. DomRuinart has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Syros Pharmaceuticals Inc. 1.702% 1.702% 73.188%
iShares Core DAX® 4.015% 2.971% 16.492%
iShares Nasdaq 100 2.755% 0.503% 40.029%
iShares Nikkei 225® -0.826% -5.057% 14.566%
iShares S&P 500 2.330% 0.720% 30.194%

According to DomRuinart what are the pros and cons of Syros Pharmaceuticals Inc. for the foreseeable future?

Pros
Could be very worthwhile Investment >20% year
Cons

Comments by DomRuinart for this prediction

In the thread Syros Pharmaceuticals Inc diskutieren
Prediction Buy
Perf. (%) 8.69%
Target price 11.600
Change
Ends at

Buy mit Kursziel 11,6

In the thread Trading Syros Pharmaceuticals Inc
Prediction Buy
Perf. (%) 8.69%
Target price 11.600
Change
Ends at 27.09.23

Buy beendet